Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H-Abu-OH (L-α-amino-n-Butyric acid) 是氨基丁酸的三个同分异构体之一,它在患有雷氏综合征,同型血尿症,酪氨酸血症,非酮糖症以及鸟氨酸转氨酶症等代谢病儿童的血浆中的含量会明显升高。
产品描述 | H-Abu-OH (L-α-amino-n-Butyric acid) , also known as (S)-2-aminobutanoic acid, homoalanine, 2-AABA, ethylglycine, or L-butyrine, is a member of the class of compounds known as L-alpha-amino acids. H-Abu-OH is a non-proteogenic amino acid that can be found in the human kidney, in liver tissues, and in most biofluids or excreta (e.g. feces, breast milk, urine, and blood). Within the cell, H-Abu-OH is primarily located in the cytoplasm. H-Abu-OH is biosynthesized by transaminating oxobutyrate, a metabolite in isoleucine biosynthesis. As a non-proteogenic amino acid, H-Abu-OH can be used by nonribosomal peptide synthases. |
别名 | L-2-氨基丁酸, L-Aminobutyric Acid, L-α-amino-n-Butyric acid, L(+)-2-Aminobutyric acid |
分子量 | 103.12 |
分子式 | C4H9NO2 |
CAS No. | 1492-24-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 10 mM
DMSO: Insoluble
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O | 1 mM | 9.6974 mL | 48.4872 mL | 96.9744 mL | 242.436 mL |
5 mM | 1.9395 mL | 9.6974 mL | 19.3949 mL | 48.4872 mL | |
10 mM | 0.9697 mL | 4.8487 mL | 9.6974 mL | 24.2436 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
H-Abu-OH 1492-24-6 Metabolism Others Endogenous Metabolite H Abu OH L-2-氨基丁酸 L-Aminobutyric Acid inhibit HAbuOH L-α-amino-n-Butyric acid L2-Aminobutyric acid L-alpha-amino-n-Butyric acid L-a-amino-n-Butyric acid L(+)-2-Aminobutyric acid Inhibitor inhibitor